Covid-19 Patients With Hypertension and/or Kidney Diseases

Not yet recruiting

• Conditions: COVID-19; Kidney Diseases; Hypertension

• Registration Number: NCT05465772
• Lead Sponsor: Assiut University

Brief Summary

1. correlation between COVID-19 and Hypertension and/or kidney diseases.

2. Assess Assess the effect of COVID-19 on patients with Hypertension and/or kidney diseases.

3. Assess the effect of hypertension and/or kidney diseases on COVID-19 presentation.

4. Assess the outcome of COVID-19 in patients with hypertension and/or kidney diseases

Detailed Description

The pandemic situation with the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus disease 2019 (COVID-19) is presented with asymptomatic, mild, or severe pneumonia-like symptoms¹.SARS-CoV-2 has infected humans in all age groups, of all ethnicities, both males and females while spreading through communities at an alarming rate². COVID-19 patients with hypertension, chronic kidney disease, Diabetes, malignancies, HIV, and other comorbidities could develop a life-threatening situation. From the data have reported the characteristics of comorbidities in patients with COVID-19, hypertension was present in nearly 21%, followed by diabetes in nearly 11%, and established cardiovascular disease (CVD) in approximately 7% of patients³.

Hypertension posed an increased risk of severe morbidity (approx. 4-fold) and death (approx. 7-fold) from COVID-19 in the presence of multiple comorbidities⁴.

The patients with underlying kidney problems are vulnerable to developing COVID-19 infection.The disease also has had consequences on longitudinal management of patients with chronic kidney disease and end stage kidney disease.

Study Timeline

• Status Verified: 2022-07
• Study Start: 2022-07
• Study First Submitted: 2022-07-18
• Study First Submitted QC: 2022-07-18
• Last Update Submitted: 2022-07-18
• Study First Posted: 2022-07-20
• Last Update Posted: 2022-07-20
• Primary Completion: 2024-08
• Study Completion: 2024-10

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Patients above 18 years old. Patients who diagnosed as COVID-19 PCR positive with hypertension and/or kidney diseases.

Exclusion Criteria

Young patients below 18 years old. Patients who refused to participate in reseach

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Covid-19 and Hypertension and/or kidney diseases	Baseline	Effect of COVID-19 on patients with Hypertension and/or kidney diseases and assess the outcome of COVID-19 in patients with hypertension and/or kidney diseases.